Ceftazidime-avibactam Versus Doripenem for the Treatment of Complicated Urinary Tract Infections, Including Acute Pyelonephritis: RECAPTURE, a Phase 3 Randomized Trial Program
出版年份 2016 全文链接
标题
Ceftazidime-avibactam Versus Doripenem for the Treatment of Complicated Urinary Tract Infections, Including Acute Pyelonephritis: RECAPTURE, a Phase 3 Randomized Trial Program
作者
关键词
-
出版物
CLINICAL INFECTIOUS DISEASES
Volume 63, Issue 6, Pages 754-762
出版商
Oxford University Press (OUP)
发表日期
2016-06-17
DOI
10.1093/cid/ciw378
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Efficacy and Safety of Ceftazidime-Avibactam Plus Metronidazole Versus Meropenem in the Treatment of Complicated Intra-abdominal Infection: Results From a Randomized, Controlled, Double-Blind, Phase 3 Program
- (2016) John E. Mazuski et al. CLINICAL INFECTIOUS DISEASES
- Ceftazidime-avibactam or best available therapy in patients with ceftazidime-resistant Enterobacteriaceae and Pseudomonas aeruginosa complicated urinary tract infections or complicated intra-abdominal infections (REPRISE): a randomised, pathogen-directed, phase 3 study
- (2016) Yehuda Carmeli et al. LANCET INFECTIOUS DISEASES
- Effects of Klebsiella pneumoniae Carbapenemase Subtypes, Extended-Spectrum β-Lactamases, and Porin Mutations on theIn VitroActivity of Ceftazidime-Avibactam against Carbapenem-Resistant K. pneumoniae
- (2015) Ryan K. Shields et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Appropriate initial antibiotic therapy in hospitalized patients with gram-negative infections: systematic review and meta-analysis
- (2015) Gowri Raman et al. BMC INFECTIOUS DISEASES
- Empiric therapy for hospital-acquired, Gram-negative complicated intra-abdominal infection and complicated urinary tract infections: a systematic literature review of current and emerging treatment options
- (2015) Yoav Golan BMC INFECTIOUS DISEASES
- Urinary tract infections: epidemiology, mechanisms of infection and treatment options
- (2015) Ana L. Flores-Mireles et al. NATURE REVIEWS MICROBIOLOGY
- The emerging threat of multidrug-resistant Gram-negative bacteria in urology
- (2015) Hosam M. Zowawi et al. Nature Reviews Urology
- In VivoEfficacy of Humanized Exposures of Ceftazidime-Avibactam in Comparison with Ceftazidime against Contemporary Enterobacteriaceae Isolates
- (2014) Shawn H. MacVane et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Efficacy of a Ceftazidime-Avibactam Combination in a Murine Model of Septicemia Caused by Enterobacteriaceae Species Producing AmpC or Extended-Spectrum β-Lactamases
- (2014) Premavathy Levasseur et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Bactericidal Activity, Absence of Serum Effect, and Time-Kill Kinetics of Ceftazidime-Avibactam against β-Lactamase-Producing Enterobacteriaceae and Pseudomonas aeruginosa
- (2014) Tiffany R. Keepers et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Healthcare-associated urinary tract infections in hospitalized urological patients—a global perspective: results from the GPIU studies 2003–2010
- (2014) Mete Cek et al. WORLD JOURNAL OF UROLOGY
- Structural Insight into Potent Broad-Spectrum Inhibition with Reversible Recyclization Mechanism: Avibactam in Complex with CTX-M-15 and Pseudomonas aeruginosa AmpC β-Lactamases
- (2013) Sushmita D. Lahiri et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Contemporary Diversity of β-Lactamases among Enterobacteriaceae in the Nine U.S. Census Regions and Ceftazidime-Avibactam Activity Tested against Isolates Producing the Most Prevalent β-Lactamase Groups
- (2013) Mariana Castanheira et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Carbapenem-resistant Enterobacteriaceae: A menace to our most vulnerable patients
- (2013) F. Perez et al. CLEVELAND CLINIC JOURNAL OF MEDICINE
- Emerging resistance problems and future perspectives in pharmacotherapy for complicated urinary tract infections
- (2013) Yen-Hsu Chen et al. EXPERT OPINION ON PHARMACOTHERAPY
- Health Care–Associated Infections
- (2013) Eyal Zimlichman et al. JAMA Internal Medicine
- Treatment of Complicated Urinary Tract Infections With an Emphasis on Drug-Resistant Gram-Negative Uropathogens
- (2013) Matthew E. Levison et al. Current Infectious Disease Reports
- Rapid evolution and spread of carbapenemases among Enterobacteriaceae in Europe
- (2012) R. Cantón et al. CLINICAL MICROBIOLOGY AND INFECTION
- Efficacy and safety of ceftazidime–avibactam versus imipenem–cilastatin in the treatment of complicated urinary tract infections, including acute pyelonephritis, in hospitalized adults: results of a prospective, investigator-blinded, randomized study
- (2012) José A. Vazquez et al. CURRENT MEDICAL RESEARCH AND OPINION
- Critical review of current definitions of urinary tract infections and proposal of an EAU/ESIU classification system
- (2011) Truls E. Bjerklund Johansen et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- Consensus review of the epidemiology and appropriate antimicrobial therapy of complicated urinary tract infections in Asia-Pacific region
- (2011) Po-Ren Hsueh et al. JOURNAL OF INFECTION
- Current Concepts in Antimicrobial Therapy Against Resistant Gram-Negative Organisms: Extended-Spectrum β-Lactamase–Producing Enterobacteriaceae, Carbapenem-Resistant Enterobacteriaceae, and Multidrug-Resistant Pseudomonas aeruginosa
- (2011) Souha S. Kanj et al. MAYO CLINIC PROCEEDINGS
- The epidemiology of urinary tract infection
- (2010) Betsy Foxman Nature Reviews Urology
- Cluster of bloodstream infections caused by KPC-2 carbapenemase-producing Klebsiella pneumoniae in Manhattan
- (2009) Abhijeet S. Nadkarni et al. AMERICAN JOURNAL OF INFECTION CONTROL
- Urinary Bactericidal Activity of Doripenem versus That of Levofloxacin in Patients with Complicated Urinary Tract Infections or Pyelonephritis
- (2009) F. M. E. Wagenlehner et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Intravenous Doripenem at 500 Milligrams versus Levofloxacin at 250 Milligrams, with an Option To Switch to Oral Therapy, for Treatment of Complicated Lower Urinary Tract Infection and Pyelonephritis
- (2009) K. G. Naber et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Emergence of clonally related Klebsiella pneumoniae isolates of sequence type 258 producing plasmid-mediated KPC carbapenemase in Norway and Sweden
- (2009) O. Samuelsen et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now